A Phase I trial of hepatic arterial bromodeoxyuridine and conformal radiation therapy for patients with primary hepatobiliary cancers or colorectal liver metastases
- 1 December 1997
- journal article
- clinical trial
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 39 (5) , 1087-1092
- https://doi.org/10.1016/s0360-3016(97)00550-6
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Effect of irradiation on bromodeoxyuridine incorporation in human colon cancer xenograftsInternational Journal of Radiation Oncology*Biology*Physics, 1996
- Analysis of clinical complication data for radiation hepatitis using a parallel architecture modelInternational Journal of Radiation Oncology*Biology*Physics, 1995
- Cell Cycle Control and CancerScience, 1994
- Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteriaInvestigational New Drugs, 1992
- A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasiaCell, 1992
- The effect of fluorodeoxyuridine on sublethal damage repair in human colon cancer cellsInternational Journal of Radiation Oncology*Biology*Physics, 1991
- Fluorodeoxyuridine-induced radiosensitization and inhibition of DNA double strand break repair in human colon cancer cellsInternational Journal of Radiation Oncology*Biology*Physics, 1990
- Intra-arterial bromodeoxyuridine radiosensitization of malignant gliomasInternational Journal of Radiation Oncology*Biology*Physics, 1990
- Liver Resection TechniquesSurgical Clinics of North America, 1989
- Hepatic arterial chemotherapy for primary and metastatic liver cancersCancer Chemotherapy and Pharmacology, 1989